Takeaway
Telomerase reverse transcriptase (TERT) promoter methylation and upregulated TERT expression is associated with disease progression, and short progression-free survival (PFS) in people with pituitary adenomas.
Why this matters
Recognising consequences of TERT abnormalities in pituitary adenomas may help inform clinical treatment decisions.